| 000 | 01572 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514034314.0 | ||
| 264 | 0 | _c20021127 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/s0264-410x(02)00189-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRafati, Sima | |
| 245 | 0 | 0 |
_aRecombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation. _h[electronic resource] |
| 260 |
_bVaccine _cJun 2002 |
||
| 300 |
_a2439-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCysteine Endopeptidases _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
| 650 | 0 | 4 |
_aLeishmania major _ximmunology |
| 650 | 0 | 4 |
_aLeishmaniasis _xprevention & control |
| 650 | 0 | 4 |
_aLymphocyte Activation _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aProtozoan Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 700 | 1 | _aKariminia, Amina | |
| 700 | 1 | _aSeyde-Eslami, Shiva | |
| 700 | 1 | _aNarimani, Manijeh | |
| 700 | 1 | _aTaheri, Tahere | |
| 700 | 1 | _aLebbatard, Mai | |
| 773 | 0 |
_tVaccine _gvol. 20 _gno. 19-20 _gp. 2439-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(02)00189-5 _zAvailable from publisher's website |
| 999 |
_c11953286 _d11953286 |
||